Bio-Techne Declares Dividend

Rhea-AI Summary

Bio-Techne (NASDAQ: TECH) announced a quarterly cash dividend of $0.08 per share for the quarter ended December 31, 2025. The dividend is payable February 27, 2026 to shareholders of record on February 16, 2026. Future dividends will be reviewed quarterly by the board.

The company reported over $1.2 billion in net sales for fiscal 2025 and has approximately 3,100 employees worldwide. The release includes standard forward-looking cautionary language about risks and uncertainties.

Positive

• Dividend declared of $0.08 per share payable Feb 27, 2026
• Record date set for Feb 16, 2026
• Fiscal 2025 net sales exceeded $1.2 billion

Negative

• Future dividends are not guaranteed; board will consider them quarterly
• Forward-looking risks noted that could affect results and share price

MINNEAPOLIS, Feb. 4, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.08 per share for the quarter ended December 31, 2025. The quarterly dividend will be payable February 27, 2026, to all common shareholders of record on February 16, 2026. Future cash dividends will be considered by the Board of Directors on a quarterly basis.

Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With thousands of products in its portfolio, Bio-Techne generated over $1.2 billion in net sales in fiscal 2025 and has approximately 3,100 employees worldwide. For more information on Bio-Techne and its brands, please visit www.bio­-techne.com.

Forward Looking Statements:
Our press releases may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act. Such statements involve risks and uncertainties that may affect the actual results of operations. Forward looking statements in this press release include statements regarding potential future repurchase of Bio-Techne common stock. The following important factors, among others, have affected and, in the future, could affect the Company's actual results and future share price: the effect of new branding and marketing initiatives, the integration of new businesses and leadership, the introduction and acceptance of new products, the funding and focus of the types of research by the Company's customers, the impact of the growing number of producers of biotechnology research products and related price competition, general economic conditions, customer site closures or supply chain issues, the impact of currency exchange rate fluctuations, and the costs and results of research and product development efforts of the Company and of companies in which the Company has invested or with which it has formed strategic relationships.

For additional information concerning such factors, see the section titled "Risk Factors" in the Company's annual report on Form 10-K and quarterly reports on Form 10-Q as filed with the Securities and Exchange Commission. We undertake no obligation to update or revise any forward-looking statements we make in our press releases due to new information or future events. Investors are cautioned not to place undue emphasis on these statements.

Contact:	David Clair, Vice President, Investor Relations
	David.Clair@bio-techne.com
	612-656-4416

View original content to download multimedia:https://www.prnewswire.com/news-releases/bio-techne-declares-dividend-302678498.html

SOURCE Bio-Techne Corporation

FAQ

What dividend did Bio-Techne (TECH) declare for the quarter ended December 31, 2025?

Bio-Techne declared a $0.08 per share quarterly cash dividend. According to the company, the dividend applies to common shareholders of record on February 16, 2026 and is payable on February 27, 2026.

When will Bio-Techne (TECH) shareholders receive the declared dividend in February 2026?

The dividend will be paid on February 27, 2026 to eligible shareholders. According to the company, shareholders must be on the record as of February 16, 2026 to receive the payment.

Does the Bio-Techne (TECH) board guarantee future dividends after this $0.08 payment?

No, future dividends are not guaranteed; they will be considered quarterly by the Board. According to the company, the Board will evaluate cash dividends each quarter based on business conditions and priorities.

How large is Bio-Techne (TECH) in revenue and workforce as of fiscal 2025?

Bio-Techne reported over $1.2 billion in net sales for fiscal 2025 and about 3,100 employees worldwide. According to the company, these figures reflect its global life-sciences product portfolio and operations.

What risks did Bio-Techne (TECH) mention alongside the dividend announcement on February 4, 2026?

The company included standard forward-looking risk factors that could affect results and share price. According to the company, risks include integration, competition, supply chain, currency, and research and development costs.